MI HB5077

Amends 2019 PA 39 to allow agencies and employees to carry, administer, and distribute opioid antagonists (naloxone) in addition to previous possession and administration authority.

Agencies may purchase or obtain opioid antagonists and distribute them to trained employees or agents, or directly to any individual under new Section 106.

Agencies are immune from civil liability for opioid antagonist distribution or administration if conduct does not amount to gross negligence that is the proximate cause of injury or death.

Employees and agents are immune from civil liability for possession, administration, failure to administer, or distribution of opioid antagonists if conduct does not amount to willful or wanton misconduct.

Agencies and employees/agents are not subject to criminal prosecution for purchasing, possessing, distributing, or administering opioid antagonists under this act; effective April 2, 2025, contingent upon enactment of HB 5078.